Multiple undefined molecular targets

Multiple undefined molecular targets is a classification used in pharmacological databases like ChEMBL and DrugBank to categorize drugs or compounds whose specific molecular mechanisms of action remain uncharacterized or involve broad, non-specific interactions (ChEMBL Database, 2024). This designation is often applied to therapeutic agents such as general anesthetics, which may interact with various lipid membranes and protein complexes, or complex botanical extracts where the active components are numerous and their individual targets are not fully defined (National Center for Biotechnology Information, 2023). Because no single protein, such as a specific receptor or enzyme, is identified as the primary mediator of the drug's effect, these agents are often studied through phenotypic assays rather than target-based approaches. The lack of a defined target complicates the rational design of derivatives and the prediction of potential off-target toxicities or drug-drug interactions (Nature Reviews Drug Discovery, 2021). Consequently, this term serves as a placeholder in drug development pipelines to indicate that the biological basis of efficacy is currently attributed to a polypharmacological or unknown profile (DrugBank Online, 2024). This classification highlights the limitations of current molecular characterization techniques for certain classes of compounds.

Other names

Unknown targetsUnspecified targetsNon-specific targetsPolypharmacological targetsUndefined molecular targets

The mechanism of action is not attributed to a single molecular entity but rather to broad, non-specific, or currently uncharacterized interactions with cellular membranes, proteins, or other biological components.